Marketing Authorisation Holder
Sinopharm
FOREIGN
6
Total Medicines
5
Active
6
Dosage Forms
1
Country
Kenya
(6)
Registration Status
Registered
5
Unknown
1
Dosage Forms
TYPE 1_>700 DU/ML, TYPE 2_>500 DU/ML, TYPE 3_>700DU/ML
1
RECEPTOR-BINDING DOMAIN (RBD) OF SARS-COV-2 SPIKE GLYCOPROTEIN (S PROTEIN)
1
EACH DOSE(0.5ML) OF INJECTION 3.3IG PFU OF LIVE VARICELLA ZOSTER VIRUS
1
ACCEPTANCE RANGE FOR ANTIGEN CONTENT: 3.9-10.4U/DOSE (TARGET ANTIGEN CONTENT: 6.5U/DOSE)
1
0.5ML/VIAL. EACH SINGLE DOSE IS 0.5ML, CONTAINING 15 MICROGRAMS OF HEMAGGLUTININ OF EACH OF THE INFLUENZA VIRUS STRAINS
1
0.5ML/DOSE/SYRINGE WHICH CONSISTS OF 23 SEROTYPES OF PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES
1
Therapeutic Classes
NEW/INNOVATOR
4
GENERIC/BIOSIMILARS
2
Local Agents / Applicants
BEIJING INSTITUTE OF...
2
WUHAN INSTITUTE OF...
1
NITRON INVESTMENTS LIMITED
1
CHENGDU RICH SCIENCE...
1
CHANGCHUN KEYGEN...
1
Registered Medicines
Showing 6 of 6